English | 简体中文 | 繁體中文 | 한국어
Share:
Tecan to present at Jefferies London Healthcare Conference

Tecan Group AG / Tecan to present at Jefferies London Healthcare Conference . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement.

Männedorf, Switzerland, November 8, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the Jefferies London Healthcare Conference on November 14, 2018.

The investor presentation by David Martyr, CEO of Tecan, will begin at 1:20 pm GMT (2:20 pm CET) and will be webcast live. The webcast may be accessed under the "Investor Relations" tab of Tecan's website www.tecan.com.

A replay of the webcast will be available after the presentation and will remain available for 90 days.

About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2017, Tecan generated sales of CHF 548 million (USD 560 million; EUR 494 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
[email protected]
www.tecan.com




This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tecan Group AG via Globenewswire

Copyright © Thomson Reuters 2019. All rights reserved.
Press Releases
Lubrizol Engineered Polymers Signs Agreement with The Institute of Chemical Technology in India  
Mar 22, 2019 20:29 ET
Nokia comments on market rumors related to its annual report on Form 20-F  
Mar 22, 2019 15:46 ET
Klövern AB (publ): Klövern's Annual report and Sustainability report for 2018  
Mar 22, 2019 14:36 ET
Lubrizol Engineered Polymers Signs Agreement with The Institute of Chemical Technology in India  
Mar 22, 2019 13:00 ET
Hexagon Composites ASA: Mandatory notification of trade - options  
Mar 22, 2019 07:55 ET
Novartis plans for Alcon spin-off on April 9, 2019  
Mar 22, 2019 07:00 ET
INGREDION INCORPORATED DECLARES QUARTERLY DIVIDEND OF $0.625 PER SHARE  
Mar 21, 2019 01:59 ET
Verisk Joins Effort to Fight Patent Trolls  
Mar 19, 2019 23:31 ET
Lubrizol Expands Again with New TPU Line in Songjiang  
Mar 19, 2019 23:29 ET
Lubrizol Completes Acquisition of Laboratoire Phenobio  
Mar 18, 2019 21:29 ET
More News >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: